Allscripts (MDRX) Misses Q3 EPS by 1c; Guides Q4 EPS Below Views
Get Alerts MDRX Hot Sheet
Join SI Premium – FREE
Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $392 million versus the consensus estimate of $414.92 million.
GUIDANCE:
Allscripts sees Q4 2016 EPS of $0.14-$0.16, versus the consensus of $0.17. Allscripts sees Q4 2016 revenue of $420-435 million, versus the consensus of $425.4 million.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crown Castle (CCI) Tops Q1 EPS by 1c; maintains outlook for FY24
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Equifax (EFX) Tops Q1 EPS by 6c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!